123 related articles for article (PubMed ID: 38164767)
1. Co-Analysis of Serum and Urine Differentially Expressed Proteins in Mucopolysaccharidosis Type I.
Liu K; Wan G; Li Y; Liang Z; Meng Y; Yuan X; Duan J
J Proteome Res; 2024 Feb; 23(2):718-727. PubMed ID: 38164767
[TBL] [Abstract][Full Text] [Related]
2. Diagnosing lysosomal storage disorders: mucopolysaccharidosis type I.
Johnson BA; Dajnoki A; Bodamer OA
Curr Protoc Hum Genet; 2015 Jan; 84():17.17.1-17.17.8. PubMed ID: 25599668
[TBL] [Abstract][Full Text] [Related]
3. Residual α-L-iduronidase activity in fibroblasts of mild to severe Mucopolysaccharidosis type I patients.
Oussoren E; Keulemans J; van Diggelen OP; Oemardien LF; Timmermans RG; van der Ploeg AT; Ruijter GJ
Mol Genet Metab; 2013 Aug; 109(4):377-81. PubMed ID: 23786846
[TBL] [Abstract][Full Text] [Related]
4. IDUA mutational profile and genotype-phenotype relationships in UK patients with Mucopolysaccharidosis Type I.
Ghosh A; Mercer J; Mackinnon S; Yue WW; Church H; Beesley CE; Broomfield A; Jones SA; Tylee K
Hum Mutat; 2017 Nov; 38(11):1555-1568. PubMed ID: 28752568
[TBL] [Abstract][Full Text] [Related]
5. [Mutation analysis of 11 Chinese patients with attenuated mucopolysaccharidosis type].
WANG XN; SHI HP; ZHANG WM; QIU ZQ; MENG Y; YAO FX; WEI M
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Apr; 28(2):147-51. PubMed ID: 21462124
[TBL] [Abstract][Full Text] [Related]
6. Identification and molecular characterization of alpha-L-iduronidase mutations present in mucopolysaccharidosis type I patients undergoing enzyme replacement therapy.
Yogalingam G; Guo XH; Muller VJ; Brooks DA; Clements PR; Kakkis ED; Hopwood JJ
Hum Mutat; 2004 Sep; 24(3):199-207. PubMed ID: 15300847
[TBL] [Abstract][Full Text] [Related]
7. Genotype-phenotype relationships in mucopolysaccharidosis type I (MPS I): Insights from the International MPS I Registry.
Clarke LA; Giugliani R; Guffon N; Jones SA; Keenan HA; Munoz-Rojas MV; Okuyama T; Viskochil D; Whitley CB; Wijburg FA; Muenzer J
Clin Genet; 2019 Oct; 96(4):281-289. PubMed ID: 31194252
[TBL] [Abstract][Full Text] [Related]
8. A deletion of IDUA exon 10 in a family of Golden Retriever dogs with an attenuated form of mucopolysaccharidosis type I.
Faller KME; Ridyard AE; Gutierrez-Quintana R; Rupp A; Kun-Rodrigues C; Orme T; Tylee KL; Church HJ; Guerreiro R; Bras J
J Vet Intern Med; 2020 Sep; 34(5):1813-1824. PubMed ID: 32785987
[TBL] [Abstract][Full Text] [Related]
9. Identification of mucopolysaccharidosis I heterozygotes based on biochemical characteristics of L-iduronidase from dried blood spots.
Campos D; Monaga M; González EC; Herrera D
Clin Chim Acta; 2014 Mar; 430():24-7. PubMed ID: 24389097
[TBL] [Abstract][Full Text] [Related]
10. Mucopolysaccharidosis type I: clinical and biochemical study.
Bassyouni HT; Afifi HH; el-Awadi MK; Meguid NA
East Mediterr Health J; 2000; 6(2-3):359-66. PubMed ID: 11556024
[TBL] [Abstract][Full Text] [Related]
11. p.X654R IDUA variant among Thai individuals with intermediate mucopolysaccharidosis type I and its residual activity as demonstrated in COS-7 cells.
Ngiwsara L; Ketudat-Cairns JR; Sawangareetrakul P; Charoenwattanasatien R; Champattanachai V; Kuptanon C; Pangkanon S; Tim-Aroon T; Wattanasirichaigoon D; Svasti J
Ann Hum Genet; 2018 May; 82(3):150-157. PubMed ID: 29282708
[TBL] [Abstract][Full Text] [Related]
12. Glycosaminoglycan fragments as a measure of disease burden in the mucopolysaccharidosis type I mouse.
Saville JT; McDermott BK; Fuller M
Mol Genet Metab; 2018 Feb; 123(2):112-117. PubMed ID: 29273385
[TBL] [Abstract][Full Text] [Related]
13. Report of 5 novel mutations of the α-L-iduronidase gene and comparison of Korean mutations in relation with those of Japan or China in patients with mucopolysaccharidosis I.
Kwak MJ; Huh R; Kim J; Park HD; Cho SY; Jin DK
BMC Med Genet; 2016 Aug; 17(1):58. PubMed ID: 27520059
[TBL] [Abstract][Full Text] [Related]
14. Detection of mucopolysaccharidosis type I heterozygotes based on the biochemical characteristics of leukocyte alpha-L-iduronidase.
Mandelli J; Wajner A; Pires RF; Giugliani R; Coelho JC
Arch Med Res; 2002; 33(1):20-4. PubMed ID: 11825626
[TBL] [Abstract][Full Text] [Related]
15. The North Carolina Experience with Mucopolysaccharidosis Type I Newborn Screening.
Taylor JL; Clinard K; Powell CM; Rehder C; Young SP; Bali D; Beckloff SE; Gehtland LM; Kemper AR; Lee S; Millington D; Patel HS; Shone SM; Woodell C; Zimmerman SJ; Bailey DB; Muenzer J
J Pediatr; 2019 Aug; 211():193-200.e2. PubMed ID: 31133280
[TBL] [Abstract][Full Text] [Related]
16. Status of newborn screening and follow up investigations for Mucopolysaccharidoses I and II in Taiwan.
Chuang CK; Lin HY; Wang TJ; Huang YH; Chan MJ; Liao HC; Lo YT; Wang LY; Tu RY; Fang YY; Chen TL; Ho HC; Chiang CC; Lin SP
Orphanet J Rare Dis; 2018 May; 13(1):84. PubMed ID: 29801497
[TBL] [Abstract][Full Text] [Related]
17. Detection of mucopolysaccharidosis type I heterozygotes on the basis of the biochemical properties of plasma alpha-L-iduronidase.
Mandelli J; Wajner A; Pires R; Giugliani R; Coelho JC
Clin Chim Acta; 2001 Oct; 312(1-2):81-6. PubMed ID: 11580912
[TBL] [Abstract][Full Text] [Related]
18. Long-term nonsense suppression therapy moderates MPS I-H disease progression.
Gunn G; Dai Y; Du M; Belakhov V; Kandasamy J; Schoeb TR; Baasov T; Bedwell DM; Keeling KM
Mol Genet Metab; 2014 Mar; 111(3):374-381. PubMed ID: 24411223
[TBL] [Abstract][Full Text] [Related]
19. Characterization of an MPS I-H knock-in mouse that carries a nonsense mutation analogous to the human IDUA-W402X mutation.
Wang D; Shukla C; Liu X; Schoeb TR; Clarke LA; Bedwell DM; Keeling KM
Mol Genet Metab; 2010 Jan; 99(1):62-71. PubMed ID: 19751987
[TBL] [Abstract][Full Text] [Related]
20. Identification of an α-l-iduronidase (IDUA) M1T mutation in a Chinese family with autosomal recessive mucopolysaccharidosis I.
Liu D; Jiang Z; Deng L; Li H; Jiang H
Ann N Y Acad Sci; 2023 Aug; 1526(1):114-125. PubMed ID: 37347427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
